Now showing items 1-3 of 3

    • Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study. 

      Swerdlow, AJ; Cooke, R; Beckers, D; Borgström, B; Butler, G; Carel, J-C; Cianfarani, S; Clayton, P; Coste, J; Deodati, A; Ecosse, E; Gausche, R; Giacomozzi, C; Hokken-Koelega, ACS; Khan, AJ; Kiess, W; Kuehni, CE; Mullis, P-E; Pfaffle, R; Sävendahl, L; Sommer, G; Thomas, M; Tidblad, A; Tollerfield, S; Van Eycken, L; Zandwijken, GRJ (2017-05)
      <h4>Context</h4>Growth hormone (GH) is prescribed for an increasing range of indications, but there has been concern that it might raise cancer risk. Published data are limited.<h4>Objective</h4>To examine cancer risks in ...
    • Menstrual cycle characteristics and steroid hormone, prolactin, and growth factor levels in premenopausal women. 

      Farland, LV; Mu, F; Eliassen, AH; Hankinson, SE; Tworoger, SS; Barbieri, RL; Dowsett, M; Pollak, MN; Missmer, SA (2017-12)
      Menstrual cycle characteristics are markers of endocrine milieu. However, associations between age at menarche and adulthood sex steroid hormone levels have been inconsistent, and data on menstrual characteristics and ...
    • Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort. 

      Swerdlow, AJ; Cooke, R; Beckers, D; Butler, G; Carel, J-C; Cianfarani, S; Clayton, P; Coste, J; Deodati, A; Ecosse, E; Hokken-Koelega, ACS; Khan, AJ; Kiess, W; Kuehni, CE; Flück, CE; Pfaffle, R; Sävendahl, L; Sommer, G; Thomas, M; Tidblad, A; Tollerfield, S; Zandwijken, GRJ (2019-03)
      Context:There has been concern that GH treatment of children might increase meningioma risk. Results of published studies have been inconsistent and limited. Objective:To examine meningioma risks in relation to GH treatment. ...